## Ticket Metadata
- **Ticket ID:** 500Qk00000CWvCOIA1
- **Case Number:** 413633
- **Status:** Closed - Resolved
- **Account/Company:** Iovance BioTherapeutics
- **Contact Name:** Michael Aquinde
- **Product:** Netwrix Endpoint Protector
- **Component:** Server
- **Feature:** Server Security Vulnerability
- **Version:** 5.9.3.0

## Problem Description
The customer reported a vulnerability related to the Endpoint Protector (EPP) server and client, requesting assistance with an update to address this issue.

## Environment Details
- **Platform:** Netwrix Endpoint Protector
- **Collector Code:** Server

## Troubleshooting Steps
1. Initial contact was made with the customer to schedule a remote session for assistance.
2. A remote session was scheduled for July 2, 2024, at 1:00 PM PST.
3. During the troubleshooting process, it was identified that a hotfix (adv-2024-002) was required to address the vulnerability.
4. The hotfix was deployed, and the server was upgraded to version 5.9.3.0.
5. Confirmation was obtained from the customer that the hotfix was applied successfully.

## Root Cause
The issue was caused by a security vulnerability in the EPP server that required an update to mitigate potential risks.

## Solution
The vulnerability was resolved by:
- Upgrading the EPP server to version 5.9.3.0.
- Applying the hotfix (adv-2024-002) to ensure the system was secure against the identified vulnerability.

## Notes
- It is important to monitor for any future hotfixes or updates that may affect the processing of events within the EPP system.
- Customers should be advised to confirm the successful application of hotfixes and updates to ensure ongoing security compliance.